Iceotope | $26,000,000 | (May 15, 2026)
Harken Sweets | Undisclosed Amount | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Certified by Founder
Lodge
Inspire Biotherapeutics Inc
start up
Canada
- Toronto, Ontario
- 17/03/2023
- Pre-Seed
- Undisclosed Amount
Inspire has developed a lung tropic AAV gene therapy platform that has demonstrated transduction and long-term expression in lung tissue without impact on other tissue types in disease-relevant animal models. We are currently pursing initiation of a Proof-of-Concept clinical trial for a lethal neonatal lung disease with short time to data readout and success of therapy. The platform can then be applied to Cystic Fibrosis and other monogenic lung diseases.
- Industry Biotechnology Research
- Website https://www.inspirebiotx.com/
- LinkedIn https://www.linkedin.com/company/inspire-biotherapeutics-inc/people/
Related People
Sandra DonaldsonFounder
Canada -
Toronto, Ontario
VP & COO OIRM. CEO & COO, Inspire Biotherapeutics. Experienced executive with a demonstrated history of nurturing research networks into thriving ecosystems while working in biotechnology and clinical trial sectors.
Ranger AI | $8,400,000 | (May 15, 2026)
Wirestock | $23,000,000 | (May 15, 2026)
GridCARE | $64,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
Novella | $21,000,000 | (May 15, 2026)
Flick | $6,000,000 | (May 15, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)